{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:37:33Z","timestamp":1794379053771,"version":"4.9.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T00:00:00Z","timestamp":1628899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013945","name":"Institut de recherches internationales Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013945","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018955","name":"Leeds Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["oarsiopenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoarthritis and Cartilage Open"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ocarto.2021.100209","type":"journal-article","created":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T01:54:04Z","timestamp":1629078844000},"page":"100209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["The design of a randomized, placebo-controlled, dose-ranging trial to investigate the efficacy and safety of the ADAMTS-5 inhibitor S201086\/GLPG1972 in knee osteoarthritis"],"prefix":"10.1016","volume":"3","author":[{"given":"Olivier","family":"Imbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Deckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"van der Aar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Pueyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Fuerst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3478-5665","authenticated-orcid":false,"given":"Philip G.","family":"Conaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Eckstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ocarto.2021.100209_bib1","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/ncprheum0841","article-title":"Drug insight: aggrecanases as therapeutic targets for osteoarthritis","volume":"4","author":"Fosang","year":"2008","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"10.1016\/j.ocarto.2021.100209_bib2","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1002\/jcb.23298","article-title":"ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis","volume":"112","author":"Verma","year":"2011","journal-title":"J.\u00a0Cell. Biochem."},{"key":"10.1016\/j.ocarto.2021.100209_bib3","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nature03369","article-title":"Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis","volume":"434","author":"Glasson","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ocarto.2021.100209_bib4","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.joca.2009.11.013","article-title":"ADAMTS-5 deficient mice do not develop mechanical allodynia associated with osteoarthritis following medial meniscal destabilization","volume":"18","author":"Malfait","year":"2010","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.ocarto.2021.100209_bib5","doi-asserted-by":"crossref","first-page":"R92","DOI":"10.1186\/ar2735","article-title":"Synovial fluid level of aggrecan ARGS fragments is a more sensitive marker of joint disease than glycosaminoglycan or aggrecan levels: a cross-sectional study","volume":"11","author":"Larsson","year":"2009","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ocarto.2021.100209_bib6","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1002\/art.22160","volume":"54","author":"Bingham","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ocarto.2021.100209_bib7","doi-asserted-by":"crossref","first-page":"R125","DOI":"10.1186\/ar3430","article-title":"A\u00a0randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee","volume":"13","author":"Cohen","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ocarto.2021.100209_bib8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.7326\/M19-0675","article-title":"Disease-modifying effects of a novel cathepsin K inhibitor in osteoarthritis: a randomized controlled trial","volume":"172","author":"Conaghan","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ocarto.2021.100209_bib9","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.2019.14735","article-title":"Effect of intra-articular sprifermin vs placebo on femorotibial joint cartilage thickness in patients with osteoarthritis: the FORWARD randomized clinical trial","volume":"322","author":"Hochberg","year":"2019","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.ocarto.2021.100209_bib10","doi-asserted-by":"crossref","first-page":"R625","DOI":"10.1186\/ar1716","article-title":"Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173]","volume":"7","author":"Spector","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ocarto.2021.100209_bib11","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/j.joca.2017.02.106","article-title":"GLPG1972: a potent, selective, orally available ADAMTS-5 inhibitor for the treatment of OA","volume":"25","author":"Clement-Lacroix","year":"2017","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.ocarto.2021.100209_bib12","article-title":"Pharmacological characterization of GLPG1972\/S201086, a potent and selective small molecule inhibitor of ADAMTS5","author":"Clement-Lacroix","year":"2021","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.ocarto.2021.100209_bib13","article-title":"Safety, pharmacokinetics and pharmacodynamics of the novel ADAMTS-5 inhibitor GLPG1972\/S201086 in healthy volunteers and participants with osteoarthritis of the knee or hip","author":"van der Aar","year":"2021","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"10.1016\/j.ocarto.2021.100209_bib14","doi-asserted-by":"crossref","first-page":"S310","DOI":"10.1016\/j.joca.2018.02.623","article-title":"ADAMTS-5 inhibitor GLPG1972, a potential new treatment in osteoarthritis, shows favorable safety, pharmacokinetics and pharmacodynamics in healthy subjects","volume":"26","author":"van der Aar","year":"2018","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.ocarto.2021.100209_bib15","doi-asserted-by":"crossref","first-page":"F1000","DOI":"10.12688\/f1000research.20575.1","article-title":"Recent advances in understanding the phenotypes of osteoarthritis","volume":"8","author":"Mobasheri","year":"2019","journal-title":"F1000Res"},{"issue":"Suppl A","key":"10.1016\/j.ocarto.2021.100209_bib16","article-title":"Atlas of individual radiographic features in osteoarthritis, revised","volume":"15","author":"Altman","year":"2007","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.ocarto.2021.100209_bib17","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.joca.2007.05.012","article-title":"Optimization of the fixed-flexion knee radiograph","volume":"15","author":"Charles","year":"2007","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.ocarto.2021.100209_bib18","first-page":"1588","article-title":"Reproducibility of the semiflexed (metatarsophalangeal) radiographic knee position and automated measurements of medial tibiofemoral joint space width in a multicenter clinical trial of knee osteoarthritis","volume":"31","author":"Buckland-Wright","year":"2004","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.ocarto.2021.100209_bib19","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1109\/TMI.2007.907323","article-title":"A\u00a0technique for regional analysis of femorotibial cartilage thickness based on quantitative magnetic resonance imaging","volume":"27","author":"Wirth","year":"2008","journal-title":"IEEE Trans. Med. Imag."},{"key":"10.1016\/j.ocarto.2021.100209_bib20","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.joca.2014.06.026","article-title":"The relationship between clinical characteristics, radiographic osteoarthritis and 3D bone area: data from the Osteoarthritis Initiative","volume":"22","author":"Barr","year":"2014","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.ocarto.2021.100209_bib21","doi-asserted-by":"crossref","first-page":"S327","DOI":"10.1016\/j.joca.2021.02.428","article-title":"Test-retest reliability and smallest detectable change (SDC) of MRI-based cartilage thickness analysis in a large multicenter randomized controlled clinical trial of knee osteoarthritis","volume":"29","author":"Eckstein","year":"2021","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.ocarto.2021.100209_bib22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/ard.2003.018457","article-title":"Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or change","volume":"64","author":"Bruynesteyn","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ocarto.2021.100209_bib23","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/art.38614","article-title":"Intraarticular sprifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: a randomized, double-blind, placebo-controlled trial","volume":"66","author":"Lohmander","year":"2014","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ocarto.2021.100209_bib24","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0140-6736(19)30417-9","article-title":"Osteoarthritis","volume":"393","author":"Hunter","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ocarto.2021.100209_bib25","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.joca.2017.07.006","article-title":"A\u00a0novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study","volume":"25","author":"Yazici","year":"2017","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.ocarto.2021.100209_bib26","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.joca.2014.05.015","article-title":"Rates and sensitivity of knee cartilage thickness loss in specific central reading radiographic strata from the osteoarthritis initiative","volume":"22","author":"Maschek","year":"2014","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.ocarto.2021.100209_bib27","doi-asserted-by":"crossref","first-page":"R74","DOI":"10.1186\/ar2272","article-title":"Risk factors associated with the loss of cartilage volume on weight-bearing areas in knee osteoarthritis patients assessed by quantitative magnetic resonance imaging: a longitudinal study","volume":"9","author":"Pelletier","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ocarto.2021.100209_bib28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.joca.2013.10.011","article-title":"Lateral and medial joint space narrowing predict subsequent cartilage loss in the narrowed, but not in the non-narrowed femorotibial compartment \u2013 data from the Osteoarthritis Initiative","volume":"22","author":"Wirth","year":"2014","journal-title":"Osteoarthritis Cartilage"},{"issue":"Suppl 120","key":"10.1016\/j.ocarto.2021.100209_bib29","first-page":"88","article-title":"Magnetic resonance imaging assessment of knee osteoarthritis: current and developing new concepts and techniques","volume":"37","author":"Hayashi","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.ocarto.2021.100209_bib30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/jama.2012.164487","article-title":"Effect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis: a randomized controlled trial","volume":"309","author":"McAlindon","year":"2013","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.ocarto.2021.100209_bib31","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1001\/jama.2017.5283","article-title":"Effect of intra-articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: a randomized clinical trial","volume":"317","author":"McAlindon","year":"2017","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.ocarto.2021.100209_bib32","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s13075-016-1149-0","article-title":"Chondroitin sulfate efficacy versus celecoxib on knee osteoarthritis structural changes using magnetic resonance imaging: a 2-year multicentre exploratory study","volume":"18","author":"Pelletier","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ocarto.2021.100209_bib33","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1002\/art.39324","article-title":"Brief report: cartilage thickness change as an imaging biomarker of knee osteoarthritis progression: data from the Foundation for the National Institutes of Health Osteoarthritis Biomarkers Consortium","volume":"67","author":"Eckstein","year":"2015","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ocarto.2021.100209_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2011.10.004","article-title":"Implementing clinical trials on an international platform: challenges and perspectives","volume":"313","author":"Minisman","year":"2012","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.ocarto.2021.100209_bib35","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.joca.2004.02.001","article-title":"OMERACT-OARSI initiative: osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited","volume":"12","author":"Pham","year":"2004","journal-title":"Osteoarthritis Cartilage"}],"container-title":["Osteoarthritis and Cartilage Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2665913121000728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2665913121000728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T09:23:07Z","timestamp":1762939387000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2665913121000728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S2665913121000728"],"URL":"https:\/\/doi.org\/10.1016\/j.ocarto.2021.100209","relation":{},"ISSN":["2665-9131"],"issn-type":[{"value":"2665-9131","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The design of a randomized, placebo-controlled, dose-ranging trial to investigate the efficacy and safety of the ADAMTS-5 inhibitor S201086\/GLPG1972 in knee osteoarthritis","name":"articletitle","label":"Article Title"},{"value":"Osteoarthritis and Cartilage Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ocarto.2021.100209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Galapagos NV. Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International (OARSI).","name":"copyright","label":"Copyright"}],"article-number":"100209"}}